Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
OTC: ABPO

Abpro Holdings, Inc.

Healthcare | Biotechnology
$0.20 -0.01 (-3.76%) as of 2026-07-14 22:00 UTC
Market Cap$10M
Volume78.0K
EPS (TTM)$-0.74

Abpro Holdings, Inc. (OTC: ABPO) is a $10M biotechnology company trading at $0.20 (−3.8% today). Figures from SEC EDGAR and market feeds; updated 2026-07-14 22:00 UTC.

52-Week Range
Low $0.09High $13.65

What Abpro Holdings, Inc. does

Abpro Holdings, Inc. is a clinical-stage biotechnology company that develops therapeutic antibodies using its DiversImmune and MultiMab antibody platforms. The company's pipeline includes product candidates such as ABP-102 and ABP-201, which are in early development stages and have not yet been tested in human subjects. Through its AbMed subsidiary, the company has in-licensed intellectual property related to ABP-201 from MedImmune (now AstraZeneca), though this program is currently paused at the IND-enabling study stage.

Summarized from Abpro Holdings, Inc.’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$0.20
Change (1D)-0.01 (-3.76%)
Market cap$10M
Volume78.0K shares
52-week range$0.09 – $13.65
Valuation
EPS (TTM)$-0.74
Returns
52-week return+133.4%
Revenue, margins & earnings
FY2023: net loss $12M on revenue $122,000$122,000FY2023FY2024: net loss $7M on revenue $183,000$183,000FY2024
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2025-08-07
Most recent filed transactions — August 2025:
  • 2025-08-07Lee Soo YoungA60,600—
  • 2025-08-04Suk Jin Wook (Miles)CEO and ChairmanBUY72,035$20.2K
  • 2025-07-29Eisenberg Anthony D.A60,600—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2025-Q4
  • Yorkville Advisors Global, LP858,333$192.3KNEW
  • CANTOR FITZGERALD, L. P.600,000$127.7K0.0%
  • VANGUARD GROUP INC20,084$85.0K-96.8%
View QoQ ownership changes →
Company news View all →
No qualifying company news in the archive. Full tape in the platform →
Questions this page answers

What does Abpro Holdings, Inc. do?

Abpro Holdings, Inc. is a biotechnology company, listed on OTC as ABPO.

What is ABPO's valuation?

ABPO trades at $0.20, as of 2026-07-14.

When did ABPO last file with the SEC?

Abpro Holdings, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 22:00 UTC. This page is also available as JSON at /api/data?ticker=ABPO and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ABPO and 3,500+ tickers.

Create a free account — keep ABPO
For your agent
GET /api/data?ticker=ABPO

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt